Business Description
Cardinal Health Inc
NAICS : 424210
SIC : 5122
7000 Cardinal Place, Dublin, OH, USA, 43017
Compare
Compare
Traded in other countries / regions
CAH.Argentina
•
C1AH34.Brazil
•
CLH.Germany
•
CAH.Mexico
•
0HTG.UK
•
CAH.USA
Description
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | -0.02 | |||||
| Debt-to-Equity | -7.5 | |||||
| Debt-to-EBITDA | 73.82 | |||||
| Interest Coverage | 11.17 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.4 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | -70.6 | |||||
| 3-Year FCF Growth Rate | 7.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 19.21 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 5.36 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 98.64 | |||||
| 9-Day RSI | 95.85 | |||||
| 14-Day RSI | 90.92 | |||||
| 6-1 Month Momentum % | 3.14 | |||||
| 12-1 Month Momentum % | 6.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.08 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 31.48 | |||||
| Days Sales Outstanding | 19.57 | |||||
| Days Payable | 51.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.82 | |||||
| 3-Year Dividend Growth Rate | 1 | |||||
| Forward Dividend Yield % | 2.84 | |||||
| 5-Year Yield-on-Cost % | 3.33 | |||||
| 3-Year Average Share Buyback Ratio | 3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.61 | |||||
| Operating Margin % | 0.92 | |||||
| Net Margin % | -0.51 | |||||
| ROE % | -168.05 | |||||
| ROA % | -2.15 | |||||
| ROIC % | 15.41 | |||||
| ROC (Joel Greenblatt) % | -19.92 | |||||
| ROCE % | -4.08 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 12.88 | |||||
| Shiller PE Ratio | 64.66 | |||||
| Price-to-Owner-Earnings | 32.65 | |||||
| PS Ratio | 0.11 | |||||
| Price-to-Free-Cash-Flow | 6.96 | |||||
| Price-to-Operating-Cash-Flow | 6.11 | |||||
| EV-to-EBIT | -31.72 | |||||
| EV-to-Forward-EBIT | 10.67 | |||||
| EV-to-EBITDA | 273.13 | |||||
| EV-to-Forward-EBITDA | 8.92 | |||||
| EV-to-Revenue | 0.11 | |||||
| EV-to-Forward-Revenue | 0.12 | |||||
| EV-to-FCF | 7.19 | |||||
| Price-to-Projected-FCF | 0.91 | |||||
| Price-to-Median-PS-Value | 0.73 | |||||
| Earnings Yield (Greenblatt) % | -3.15 | |||||
| Forward Rate of Return (Yacktman) % | 5.92 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:CAH
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 181,364 | ||
| EPS (TTM) ($) | -3.44 | ||
| Beta | 0.59 | ||
| Volatility % | 26.35 | ||
| 14-Day RSI | 90.92 | ||
| 14-Day ATR ($) | 1.846605 | ||
| 20-Day SMA ($) | 60.471 | ||
| 12-1 Month Momentum % | 6.79 | ||
| 52-Week Range ($) | 45.85 - 71.45 | ||
| Shares Outstanding (Mil) | 272.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardinal Health Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||